Exane Derivatives’s Newmont NEM Stock Holding History
Bought
Maintained
Sold
Other funds holding NEM
Exane Derivatives's NEM Position: Q2 2022 in Review
Exane Derivatives reduced its Newmont (NEM) stake by 77% in Q2 2022, selling an estimated $447K and leaving 1,857 shares worth $111K. The position accounts for 0.06% of the portfolio, ranked #253.
Exane Derivatives first reported a position in NEM in Q4 2014 and has held it in 26 quarters since. The position peaked at $1.24M in Q4 2016. 1,093 funds tracked by Wall St. Rank hold NEM as of Q2 2022.
- Exane Derivatives held 1,857 shares of Newmont worth $111K as of Q2 2022.
- Exane Derivatives sold 6,324 Newmont shares in Q2 2022, an estimated $447K.
- Newmont made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #253 holding.
- Exane Derivatives first reported a position in Newmont in Q4 2014 and has held it in 26 quarters since.
- Exane Derivatives's Newmont position peaked at $1.24M in Q4 2016.
- 1,093 funds tracked by Wall St. Rank held Newmont as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.